v3.26.1
UNAUDITED CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS - USD ($)
 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities        
Net loss $ (15,727,338) $ (4,587,534) $ (16,543,616) $ (7,908,777)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation 187,952 10,161 36,408 15,319
ROU asset amortization 30,001 43,175 88,738 77,383
Unrealized gain on investments (55,987) (25,050) (29,664) (5,474)
Realized gain on investments (140,969) 0 (40,911) (6,881)
Amortization of debt discount 0 238,981 500,937 1,777,505
Change in fair value of derivative liability 0 548,763 970,866 1,642,697
Stock-based compensation 4,464,752 0 6,069,560 0
Loss on disposal of property, plant, and equipment 4,603 0    
Impairment of aircraft deposits 5,150,000 0    
Write-off of other receivable     1,064 0
Changes in operating assets and liabilities:        
Accrued interest 0 (248,643) (516,445) (397,517)
Other receivable     0 (1,064)
Accounts payable and accrued liabilities 376,779 305,770 234,332 255,194
Due from related parties     (6,833) 0
Due from shareholder 6,833 (21,991)    
Deferred income (14,998) (124,800) (195,800) (52,200)
Grant payable 365,000 (51,511) 354,967 0
Prepaid expenses (4,680,890) (29,770) (96,116) 19,868
Lease liability (26,144) (43,425) (87,749) (75,801)
Net cash used in operating activities (10,060,406) (3,488,588) (8,227,372) (3,864,714)
Cash flows from investing activities        
Additions to long-term deposits 0 (6,000,000) (5,945,911) (550,000)
Purchase of property and equipment (111,167) 0 (150,763) 0
Purchase of short-term investments (25,811,038) (318,603) (16,560,779) (1,295,252)
Redemption of short-term investments 19,043,594 0 2,363,696 589,200
Net cash used in investing activities (6,878,611) (6,318,603) (20,293,757) (1,256,052)
Cash flows from financing activities        
Repayment of related party notes payable (1,526,126) 0 (100,000) (45,000)
Proceeds from private placements 17,499,995 6,919,701    
Cash paid for financing costs (1,267,000) (398,878) (3,157,638) (841,337)
Issuance costs for convertible debentures     0 (19,950)
Proceeds from convertible debentures     0 743,400
Proceeds from Regulation A financing     7,247,931 10,690,243
Proceeds from Initial Public Offering     22,061,857 0
Net cash provided by financing activities 14,706,869 6,520,823 26,052,150 10,527,356
Decrease in cash and restricted cash (2,232,148) (3,286,368) (2,468,979) 5,406,590
Cash and restricted cash, beginning of period 4,631,720 7,100,699 7,100,699 1,694,109
Cash and restricted cash, end of period 2,399,572 3,814,331 4,631,720 7,100,699
Cash 1,452,854 3,763,993 4,581,128 7,050,610
Restricted cash 946,718 50,338 50,592 50,089
Total cash and restricted cash, end of period 2,399,572 3,814,331 4,631,720 7,100,699
Supplemental cash flow information        
Income taxes paid 0 0 0 0
Interest paid 0 21,899 39,539 89,152
Supplemental disclosure of non-cash investing and financing activities        
Right of use asset additions     20,372 0
Right of use asset modifications     303,611 0
Shares issued for common stock subscribed 0 1,870,643 1,870,643 0
Deferred financing costs recognized as share issuance costs 0 105,703 105,703 0
Notes and interest payable converted into shares     1,451,480 0
Convertible debentures and derivative liabilities converted into shares     13,767,137 0
Initial derivative liability from issuance of convertible notes     $ 0 $ 475,909
Property, plant, and equipment additions in accounts payable and accrued liabilities 476 0    
Financing costs in accounts payable and accrued liabilities $ 93,015 $ 0